Unofficial; not affiliated with the European Commission. Source: European Commission, EU Funding & Tenders Portal. Reused under the Commission's reuse policy (Decision 2011/833/EU, CC BY 4.0); we reorganise the facts and add counts.
Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies
Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies (HORIZON-MISS-2027-02-CANCER-06) is a forthcoming funding topic under Horizon Europe with a stated budget of €3 million. The next deadline is , 334 days away as of . It is planned to open on .
In our daily copy of EU Funding & Tenders Portal data (), 5 other topics in call HORIZON-MISS-2027-02 are listed; Horizon Europe has 376 open or forthcoming calls here; the median stated budget for Horizon Europe calls is €12 million; 107 Horizon Europe calls have a deadline in September 2027.
| Identifier | HORIZON-MISS-2027-02-CANCER-06 |
|---|---|
| Programme | Horizon Europe |
| Status | Forthcoming |
| Opening date | |
| Deadline | |
| Submission | Single-stage |
| Type of action | Horizon Europe Coordination and Support Actions |
| Budget | €3 million (2027 budget) |
| Expected number of grants | 1 |
| EU contribution per project | €3 million |
| Call | HORIZON-MISS-2027-02 — Supporting the implementation of the Cancer Mission |
| Themes on this site | Health |
| Cross-cutting priorities (portal) | Digital Agenda, Artificial Intelligence |
| Portal keywords | Child health, Health inequalities, Public health, Quality of health care, Rehabilitation, Rights of the child, National funders, Philanthropy, late-effects, quality of life |
Read the official topic page on the EU Funding & Tenders Portal
Type of action
Coordination and support actions fund networking, coordination, dissemination, policy support and similar accompanying measures, rather than research itself.
Deadline
Deadline as published: . Check the official page for the exact time and any changes; late submissions are not accepted.
Next steps
- Open the official topic page and read the conditions, the call document and the evaluation criteria.
- Create a free EU Login and register your organisation to get a PIC, if you do not have one.
- Find partners if the topic needs a consortium (the portal's partner search is free).
- Start a draft in the submission system from the topic page and submit before the deadline.
New to EU funding? Read how to apply for EU funding.
Related calls
- Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers — HORIZON-MISS-2027-02-CANCER-02, next deadline
- Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research — HORIZON-MISS-2027-02-CANCER-04, next deadline
- Leveraging functional genomics to reveal novel targets for cancer treatment — HORIZON-MISS-2027-02-CANCER-01, next deadline
- Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes — HORIZON-MISS-2027-02-CANCER-03, next deadline
- Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines — HORIZON-MISS-2027-02-CANCER-05, next deadline
- Biotechnology for Healthy Ageing — HORIZON-EIC-2026-PATHFINDERCHALLENGES-01-02, next deadline
- Development of innovative tools, processes, equipment and technologies through responses to disasters and emergencies for search and rescue in hazardous conditions — HORIZON-CL3-2026-01-DRS-03, next deadline
- Multi-hazard approach and cumulative / cascading impacts — HORIZON-CL3-2026-01-DRS-02, next deadline
- Open topic on driving innovation uptake of disaster risk solutions — HORIZON-CL3-2026-01-DRS-04, next deadline
- Targeted innovative capabilities for the resilience of critical entities to natural and human-induced disasters, including hybrid scenarios — HORIZON-CL3-2026-01-INFRA-03, next deadline